Microbot Medical ( (MBOT) ) just unveiled an update. On October 1, 2025, Microbot Medical announced that it has received its first patent in Japan for its core LIBERTY® System technology, which ...
Microbot Medical® Receives First Patent in Japan as it Continues to Broaden its Global Intellectual Property PortfolioCommercial Focus Remains on U.S. Market as it Continues to Explore Certain Global ...
THE Department of Science and Technology (DOST) distributed robotics kits amounting to P4.8 million to provide students in 11 ...
Microbot Medical (MBOT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).